Nanomedicines for the Delivery of Biologics
A special symposium of the Academy of Pharmaceutical Sciences Nanomedicines Focus Group reviewed the current status of the use of nanomedicines for the delivery of biologics drugs. This meeting was particularly timely with the recent approval of the first siRNA-containing product Onpattro™...
Saved in:
Main Authors: | John Wahlich (Author), Arpan Desai (Author), Francesca Greco (Author), Kathryn Hill (Author), Arwyn T. Jones (Author), Randall J. Mrsny (Author), Gianfranco Pasut (Author), Yvonne Perrie (Author), F. Philipp Seib (Author), Leonard W. Seymour (Author), Ijeoma F. Uchegbu (Author) |
---|---|
Format: | Book |
Published: |
MDPI AG,
2019-05-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Targeting Intracranial Tumours with a Combination of RNA and Chemotherapy
by: Abdulhamid S. Fatani, et al.
Published: (2024) -
Nanomedicines
Published: (2019) -
Re-Assessing PK/PD Issues for Oral Protein and Peptide Delivery
by: Randall J. Mrsny, et al.
Published: (2021) -
Cancer Nanomedicine
Published: (2020) -
The era of nanomedicine
by: Ana Grenha
Published: (2011)